Your browser doesn't support javascript.
loading
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy.
Cabrera-Galeana, Paula; Muñoz-Montaño, Wendy; Lara-Medina, Fernando; Alvarado-Miranda, Alberto; Pérez-Sánchez, Victor; Villarreal-Garza, Cynthia; Quintero, R Marisol; Porras-Reyes, Fany; Bargallo-Rocha, Enrique; Del Carmen, Ignacio; Mohar, Alejandro; Arrieta, Oscar.
Afiliação
  • Cabrera-Galeana P; Department of Breast Medical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Muñoz-Montaño W; Department of Breast Medical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Lara-Medina F; Department of Breast Medical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Alvarado-Miranda A; Department of Breast Medical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Pérez-Sánchez V; Department of Breast Pathology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Villarreal-Garza C; Department of Breast Medical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Quintero RM; Department of Medical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Porras-Reyes F; Department of Breast Pathology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Bargallo-Rocha E; Department of Breast Surgical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Del Carmen I; Department of Breast Surgical Oncology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Mohar A; Unit of Breast Epidemiology, National Institute of Cancer (INCan), Mexico City, Mexico.
  • Arrieta O; Unit of Thoracic Oncology and Personalized Medicine Laboratory, National Institute of Cancer (INCan), Mexico City, Mexico ogar@unam.mx.
Oncologist ; 23(6): 670-678, 2018 06.
Article em En | MEDLINE | ID: mdl-29490940

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antígeno Ki-67 / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antígeno Ki-67 / Terapia Neoadjuvante Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: México